Synbiotech and Lonza Announce Exclusive Partnership of Development and Sales of Sport Probiotics TWK10(R) for Nutrition Markets in EU and US
PR85687
KAOSHIUNG, Sept. 23, 2020 /PRNewswire=KYODO JBN/--
Synbiotech and Lonza announce an exclusive collaboration agreement on
Lactobacillus plantarum TWK10(R) under which Lonza will exclusively
commercialize the innovative probiotic TWK10(R) in the US, Canada, Europe and
Brazil whilst at the same time both companies will collaborate to further
develop and optimize TWK10(R) and explore new markets and applications.
Photo - https://photos.prnasia.com/prnh/20200918/2921748-1
Founded in Switzerland in 1897, Lonza is a leading global partner to the
pharmaceutical, biotech and specialty ingredients markets, and is one of the
leading CDMO (Contract Development and Manufacturing Organization) groups in
the globe. Dr. Thomas Kiy, Vice President Strategy and Portfolio Development of
Lonza commented, "We have defined Sports Nutrition & Active Living as one of
our strategic growth areas and Synbiotech's innovative TWK10(R) probiotic is a
perfect complementation of our portfolio in this market. We are excited to launch
the first of it's kind sport probiotic product in North America and Europe very soon."
Lactobacillus plantarum TWK10(R), extracted from Taiwanese Kimchi, is a
research achievement with collaboration between Synbiotech and academics.
Study[1] has shown that it can increase muscle endurance, improve body
composition and exercise performance and reduce fatigue. Currently two human
clinical papers have been published with US and Taiwan patents obtained.
Moreover, TWK10(R) achieved US Self-affirmed GRAS on 29 May 2020, and it
becomes the first certified raw material of lactic acid bacteria in local Taiwan.
Dr. San Land Young, human healthcare global operation head of Synbiotech
commented, "EU and Japan were leading the global probiotic markets for years,
while now the sport probiotics TWK10(R) from Taiwan has attracted attention
during its research and development period. Since the clinical trial was
reported on Nutrients Scientific Magazine, it has been published dozens of
times on international seminars and aroused more attention in scientific
community. Lonza expressed its interest on TWK10(R) on European international
probiotics seminar early 2019, two companies then started more than one year
negotiation and eventually defined the collaboration direction, which has set a
significant milestone to the internationalization of Taiwan's probiotic industry."
Mr. Kuie-ming Lee, Vice President of Human Healthcare of Synbiotech said,
"Local-developed TWK10(R) is one of the most remarkable sports probiotics in
global market. Synbiotech and Lonza will leverage their respective strength on
scientific research and market operation, and jointly explore TWK10(R)'s sports
nutrition market in EU and US under the principle of win-win and mutual
development. On top of cooperation with Lonza Group, Synbiotech is seeking any
kind of cooperation that could expand the market for TWK10(R) and will be
gradually deploying its international network during 2020-2021, and we are
convinced that TWK10(R) probiotic products will be launched soon throughout the
major global markets in EU, North America, Southeast Asia, Japan, Korea and China."
[1]Effect of Lactobacillus Plantarum TWK10 on Exercise Physiological
Adaptation, Performance, and Body Composition in Healthy Humans. Nutrients
2019. 11(11), 2019, 2836.
Media Contact:
Lisa Chen
lisa.chen@synbiotech.com.tw
+886-7-6955680ext271
SOURCE Synbiotech
Image Attachments Links:
Link: http://asianetnews.net/view-attachment?attach-id=372064
Caption: Synbiotech and Lonza Announce Exclusive Partnership of Development and Sales of
Sport Probiotics TWK10(R) for Nutrition Markets in EU and US
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。